Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2010 042 156.2 |
96 | EP file number | EAKZ | 14 18 4157.7 |
97 | EP publication number | EPN | 2813238 |
54 | Designation/title | TI | Verwendung von Neuregulin zur Behandlung von peripheren Nervenläsionen |
51 | IPC main class | ICM (ICMV) | A61K 38/18 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 25/02 (2006.01) |
22 | DE application date | DAT | Oct 14, 2010 |
96 | EP application date | EAT | Oct 14, 2010 |
43 | Date of first publication | OT | Dec 17, 2014 |
| Date of publication of grant | PET | May 3, 2017 |
71/73 | Applicant/owner | INH | Acorda Therapeutics, Inc., Ardsley, N.Y., US |
72 | Inventor | IN | Caggiano, Anthony, O., Larchmont, NY New York 10538, US; Bella, Anthony, J., Ottawa, Ontario K2R 1A6, CA; Iaci, Jennifer, F., Boonton, NJ New Jersey 07005, US |
74 | Representative | VTR | Maikowski & Ninnemann Patentanwälte Partnerschaft mbB, 10707 Berlin, DE |
| Address for service | | Maikowski & Ninnemann Patentanwälte Partnerschaft mbB, 10671 Berlin, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 252161 P Oct 16, 2009
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 251583 P Oct 14, 2009
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002813238 Searchable text:
EP000002813238 Original document:
EP000002813238B1 Searchable text:
EP000002813238B1 |
43 | Date of first publication | EVT | Dec 17, 2014 |
| Date of the first transfer into DPMAregister | EREGT | Jan 30, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 3, 2023 (Show all update days)(Hide all update days)Jan 30, 2015; Aug 25, 2016; May 4, 2017; Jun 8, 2017; Aug 1, 2017; Nov 8, 2017; Mar 29, 2018; May 3, 2018; Nov 8, 2018; Jul 11, 2019; Aug 19, 2019; Nov 8, 2019; Nov 5, 2020; Oct 9, 2021; Jun 18, 2023; Aug 3, 2023 |